Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FQ0C4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,257
Award facts
- Contract value 100% obligated
- $16,257.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,257.30 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder pharmaceutical product used in respiratory disease management. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly within military and veteran healthcare systems. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
The delivery order fulfills the Defense Logistics Agency's pharmaceutical supply requirements through AmerisourceBergen Drug Corp's established IDC vehicle, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a child contract under the SPE2DX prime IDV, this award demonstrates the contractor's ongoing capability to meet federal procurement requirements for specialty medications and brand-name pharmaceuticals in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects DLA's continued reliance on established pharmaceutical vendor relationships to maintain medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FQ0C4?
SPE2DB25FQ0C4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FQ0C4 worth?
The government has obligated $16,257 on SPE2DB25FQ0C4.
Is contract SPE2DB25FQ0C4 an order under another contract?
Yes. SPE2DB25FQ0C4 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0C4 competed?
The extent of competition for SPE2DB25FQ0C4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award